An Open-label Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study)
Public ClinicalTrials.gov record NCT05037851. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Controlled Open-label Study to Assess the Safety and Tolerability of Nebulized PC945 for Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to evaluate the safety and tolerability of opelconazole for the prevention of fungal aspergillus infections in the lung in participants who have received a lung transplant.
Study identification
- NCT ID
- NCT05037851
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 102 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 18, 2021
- Primary completion
- Oct 18, 2023
- Completion
- Nov 12, 2023
- Last update posted
- Apr 29, 2026
2021 – 2023
United States locations
- U.S. sites
- 17
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Site | Phoenix | Arizona | 85013 | — |
| Clinical Research Site | La Jolla | California | 92037 | — |
| Clinical Research Site | Los Angeles | California | 90095 | — |
| Clinical Research Site | Jacksonville | Florida | 32224 | — |
| Clinical Research Site | Tampa | Florida | 33606 | — |
| Clinical Research Site | Maywood | Illinois | 60153 | — |
| Research Site | St Louis | Missouri | 63110 | — |
| Clinical Research Site | New York | New York | 10016 | — |
| Clinical Research Site | The Bronx | New York | 10467 | — |
| Clinical Research Site | Philadelphia | Pennsylvania | 19104 | — |
| Clinical Research Site | Philadelphia | Pennsylvania | 19140 | — |
| Clinical Research Site | Pittsburgh | Pennsylvania | 15213 | — |
| Clinical Research Site | Nashville | Tennessee | 37232 | — |
| Clinical Research Site | Dallas | Texas | 75246 | — |
| Clinical Research Site 1 | Houston | Texas | 77030 | — |
| Clinical Research Site 2 | Houston | Texas | 77030 | — |
| Clinical Research Site 3 | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05037851, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2026 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05037851 live on ClinicalTrials.gov.